Omrix Biopharmaceuticals News (NASDAQ:OMRI)

Latest Omrix Biopharmaceuticals News Headlines
DateTimeSource
Headline
09/18/20078:00AMPRNUSPeptimmune Appoints Fredric Price as Chairman and Reorganizes its Board of Directors
CAMBRIDGE, Mass., Sept. 18 /PRNewswire/ -- Peptimmune, Inc. a privately held biotechnology company, announced that Fredric D. Price has been appointed Executive Chairman of the Board of Directors. Mr. Price brings more than 30 years of biotechnology and pharmaceuticals industry experience to the company, including... More...>>
07/05/20068:30AMPRNUSSymphony Medical Announces Initiation of Phase II Multi-Center Clinical Trial for Biologic Therapy to Prevent Post-Operative At
Study Intended to Validate Efficacy and Move Novel Technology Closer to Commercialization LAGUNA HILLS, Calif., July 5 /PRNewswire/ -- Symphony Medical, Inc., a developer of new non-destructive biologic and biopolymer therapies to treat atrial fibrillation and other cardiac abnormalities, announced today patient enrollment... More...>>


LSE and PLUS quotes are live. NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Request an Exchange :: Affiliate Scheme
Copyright1999-2008 ADVFN PLC. Copyright and limited reproduction :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs
ADDITIONAL SERVICES AVAILABLE FROM ADVFN
Upgrade - Click here for more information on ADVFN premium services Money Words - ADVFN Financial Glossary Investor Training ADVFN Financial Bookshop Online Training Academy
43 site:2us nasdaq omri081013 13:25 Stock Message Boards ( 2001 | 2002 | 2003 | 2004 | 2005 | 2005 | 2007 )